Would prostate cancer detected by screening withprostate‐specific antigen develop into clinical cancer if left undiagnosed? A comparison of two population‐based studies in Sweden
暂无分享,去创建一个
J. Hugosson | H. Lilja | G. Aus | G. Tibblin | P. Lodding | S. Carlsson | C. Becker | H. Eriksson
[1] E. Varenhorst,et al. The cost of prostatic cancer in a defined population. , 1989, Scandinavian journal of urology and nephrology.
[2] J. Hugosson,et al. Need for hospital care and palliative treatment for prostate cancer treated with noncurative intent. , 1995, The Journal of urology.
[3] P. Humphrey,et al. Prospective characterization of pathological features of prostatic carcinomas detected via serum prostate specific antigen based screening. , 1996, The Journal of urology.
[4] J. Oesterling,et al. Long-term (15 years) results after radical prostatectomy for clinically localized (stage T2c or lower) prostate cancer. , 1994, The Journal of urology.
[5] P C Prorok,et al. Prostate Cancer Screening: What We Know and What We Need To Know , 1993, Annals of Internal Medicine.
[6] J. Hugosson,et al. Surveillance is not a viable and appropriate treatment option in the management of localized prostate cancer. , 1996, The Urologic clinics of North America.
[7] J. Hugosson,et al. Long-term survival and mortality in prostate cancer treated with noncurative intent. , 1995, The Journal of urology.
[8] J. Hugosson,et al. Characteristics of screening detected prostate cancer in men 50 to 66 years old with 3 to 4 ng./ml. Prostate specific antigen. , 1998, The Journal of urology.
[9] B. G. Blijenberg,et al. The value of screening tests in the detection of prostate cancer. Part I: Results of a retrospective evaluation of 1726 men. , 1995, Urology.
[10] S. Fosså,et al. The burden of prostate cancer from diagnosis until death. , 1995, British journal of urology.
[11] H. Adami,et al. Ethics of a prostate cancer screening trial , 1994, The Lancet.
[12] P. Troncoso,et al. Tumor volume and prostate specific antigen: implications for early detection and defining a window of curability. , 1995, The Journal of urology.
[13] R. A. Jones,et al. Immediate versus deferred treatment for advanced prostatic cancer: initial results of the Medical Research Council Trial. The Medical Research Council Prostate Cancer Working Party Investigators Group. , 1997, British journal of urology.
[14] R. Vessella,et al. Screening for prostatic carcinoma with prostate specific antigen. , 1992, The Journal of urology.
[15] H. Adami,et al. The value of prostate specific antigen in early diagnosis of prostate cancer: the study of men born in 1913. , 1995, The Journal of urology.
[16] N. Bolton,et al. Nuclear androgen receptors in the epithelium and stroma of human benign prostatic hypertrophic glands , 1983, The Prostate.
[17] D. Fryback,et al. Long-term survival among men with conservatively treated localized prostate cancer. , 1995, JAMA.
[18] Curtis Mettlin,et al. Defining and updating the american cancer society guidelines for the cancer‐related checkup: Prostate and endometrial cancers , 1993, CA: a cancer journal for clinicians.
[19] J. Oesterling,et al. In vitro stability of free prostate-specific antigen (PSA) and prostate-specific antigen (PSA) complexed to alpha 1-antichymotrypsin in blood samples. , 1996, Urology.
[20] J. Goméz,et al. Diagnosis of advanced or noncurable prostate cancer can be practically eliminated by prostate-specific antigen. , 1996, Urology.
[21] M. Stampfer,et al. A prospective evaluation of plasma prostate-specific antigen for detection of prostatic cancer. , 1995, JAMA.
[22] W. Catalona,et al. Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. , 1991, The New England journal of medicine.
[23] P. Knekt,et al. Serum concentrations of prostate specific antigen and its complex with α1-antichymotrypsin before diagnosis of prostate cancer , 1994, The Lancet.
[24] Z. Hall. Cancer , 1906, The Hospital.
[25] Igor Sartori,et al. Detection of Organ-Confined Prostate Cancer Is Increased Through Prostate- Specific Antigen-Based Screening: , 1994 .
[26] W. Catalona,et al. Detection of organ-confined prostate cancer is increased through prostate-specific antigen-based screening. , 1993, JAMA.
[27] M. Garnick,et al. Prostate Cancer: Screening, Diagnosis, and Management , 1993, Annals of Internal Medicine.
[28] F. Schröder,et al. The TNM classification of prostate cancer , 1992, The Prostate. Supplement.
[29] P. Björntorp,et al. The Pituitary-Gonadal Axis and Health in Elderly Men: A Study of Men Born in 1913 , 1996, Diabetes.